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Abstract: Breath analysis, a promising new field of medicine and medical instrumentation, 
potentially offers noninvasive, real-time, and point-of-care (POC) disease diagnostics and 
metabolic  status  monitoring.  Numerous  breath  biomarkers  have  been  detected  and 
quantified so far by using the GC-MS technique. Recent advances in laser spectroscopic 
techniques and  laser sources  have driven  breath analysis to new heights,  moving  from 
laboratory  research  to  commercial  reality.  Laser  spectroscopic  detection  techniques  not 
only have high-sensitivity and high-selectivity, as equivalently offered by the MS-based 
techniques,  but  also  have  the  advantageous  features  of  near  real-time  response,  low 
instrument  costs,  and  POC  function.  Of  the  approximately  35  established  breath 
biomarkers,  such  as  acetone,  ammonia,  carbon  dioxide,  ethane,  methane,  and  nitric  
oxide, 14 species in exhaled human breath have been analyzed by high-sensitivity laser 
spectroscopic techniques, namely, tunable diode laser absorption spectroscopy (TDLAS), 
cavity  ringdown  spectroscopy  (CRDS),  integrated  cavity  output  spectroscopy  (ICOS), 
cavity enhanced absorption spectroscopy (CEAS), cavity leak-out spectroscopy (CALOS), 
photoacoustic spectroscopy (PAS), quartz-enhanced photoacoustic spectroscopy (QEPAS), 
and  optical  frequency  comb  cavity-enhanced  absorption  spectroscopy  (OFC-CEAS). 
Spectral fingerprints of the measured biomarkers span from the UV to the mid-IR spectral 
regions  and  the  detection  limits  achieved  by  the  laser techniques  range  from  parts  per 
million to parts per billion levels. Sensors using the laser spectroscopic techniques for a 
few breath biomarkers, e.g., carbon dioxide, nitric oxide, etc. are commercially available. 
This review presents an update on the latest developments in laser-based breath analysis. 
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1. Introduction 
 
It is generally accepted that modern breath analysis started with the discovery made by Pauling in 
1971 that hundreds of volatile organic compounds (VOCs) are present in normal human breath at the 
levels  of  parts  per  billion  (ppb)  or  lower  [1].  This  discovery,  together  with  other  early  breath  
studies  [2],  has  regenerated  research  interest  in  human  breath  analysis  for  noninvasive  disease 
diagnosis and metabolic status monitoring. Breath analysis can be classified into two groups: analysis 
of breath metabolites after administration of a drug or substrate and analysis of breath compounds 
produced endogenously due to a particular physiological status. Normal human breath contains a few 
atmospheric molecules, e.g., H2O, CO2, N2, O2, in relatively high concentrations, several VOCs, e.g., 
acetone, isoprene, propanols, etc., at the parts per million (ppm) or sub ppm levels, and about four 
hundred major VOCs (of more than 1,000 breath compounds) at the ppb or parts per trillion (ppt) 
levels  [1,3,4].  To  date,  some  VOCs  have  been  established  as  biomarkers  for  specific  diseases  or 
metabolic disorders. For instance, alkanes are present in the case of lung cancer and formaldehyde in 
the case of breast cancer; the presence of isoprene in human breath is related to blood cholesterol 
levels; and patients with Type 1 diabetes have excess acetone in their breath. Such knowledge suggests 
that breath analysis is useful for human disease diagnosis and/or metabolic status monitoring. However, 
due to the low concentrations and large quantity of trace compounds in exhaled breath, breath analysis 
requires  a  highly  sensitive  and  highly  selective  instrument  in  order  to  identify  and  determine 
concentrations of specific biomarkers. One major technique primarily employed for breath gas analysis 
is gas chromatography-mass spectrometry (GC-MS). This method has a routine detection sensitivity of 
ppb to ppt and can analyze multiple compounds simultaneously and selectively; yet, GC-MS requires 
complicated  procedures  for  sample  collection  and  pre-concentration  and  also  has  high  instrument  
costs [5-7]. Extensive studies have been conducted to identify and quantify breath biomarkers using 
GC-MS, to improve the  methods of  breath  sample  preparation, and to miniaturize devices [8-13]. 
However,  current  MS-based  breath  analyses  are  still  limited  to  laboratory  research,  beyond  the 
consideration  of  an  affordable,  real-time,  point-of-care  (POC)  clinical  instrument.  In  addition  to 
conventional GC-MS methods, a relatively new technique, proton transfer reaction mass spectrometry 
(PTR-MS), has been used for breath profiling [14,15]. Vacuum-free ion mobility spectroscopy (IMS) 
combined  with  a  multi-capillary  column  has  also  been  used  for  identification  of  metabolites  and 
bacteria in human breath [16,17]. IMS is slightly less sensitive than GC-MS and PTR-MS and shows 
much potential for the development of a hand-held breath device. By comparison, selected ion flow 
tube  mass  spectrometry  (SIFT-MS),  which  also  belongs  to  the  MS-based  category,  performs 
exceptionally well in clinical breath analysis; on-line breath analysis of many breath compounds under 
various physiological conditions have been conducted in clinics with actual human breath [18-21]. 
Breath analysis is also conducted by using electrical sensors, which are comparatively inexpensive and 
smaller in size, but they have low detection selectivity and require frequent calibrations [22,23].  Sensors 2009, 9                         
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Recent advances in high-sensitivity, high-selectivity laser spectroscopic techniques as well as laser 
sources  make  it  possible  for  breath  analysis  to  advance  from  the  MS-based,  time-consuming, 
laboratory studies to laser-based, real-time, clinical testing [24,25]. Many breath biomarkers have been 
detected by the  laser-based techniques, and detection sensitivities are comparable with those  from  
MS-based measurements, e.g., ranging from the ppm to ppt levels. Several excellent reviews have 
discussed the current status, trends, and challenges of clinical breath analysis, the MS-based analytical 
techniques  in  breath  analysis,  and  advanced  laser  techniques  and  laser  sources  in  breath  
analysis [25-30]. This article gives an exhaustive review on the breath analysis of almost all of the 
biomarkers that have been analyzed to date in actual human breath  using the high-sensitivity laser 
spectroscopic techniques. In addition, this article differentiates itself from previous reviews [25-30] by 
presenting a complete survey of spectral fingerprints, measuring techniques, and currently achieved 
detection  limits  of  each  of  the  biomarkers.  Finally,  in  this  review,  the  high-sensitivity  laser 
spectroscopic  techniques  are  restricted  to  the  tunable  diode  laser  absorption  spectroscopy  
(TDLAS)  [31,32],  cavity  ringdown  spectroscopy  (CRDS)  [33-36],  integrated  cavity  output 
spectroscopy (ICOS) [37-40], cavity enhanced absorption spectroscopy (CEAS) [41], cavity leak-out 
absorption spectroscopy (CALOS) [42-46], photoacoustic spectroscopy (PAS) [47], quartz-enhanced 
photoacoustic spectroscopy (QEPAS) [48], and optical frequency comb cavity-enhanced absorption 
spectroscopy (OFC-CEAS) [49,50]. The paper is structured as follow: Section 2 of this article lists  
the 35 major breath biomarkers which have been identified and quantified to date by all detection 
means, including MS-, chemical-, and laser-based techniques; in Section 3, the key principles of the 
TDLAS, CRDS, ICOS, CEAS, CALOS, PAS, QEPAS, and OFC-CEAS are briefly described with a 
common  feature  of  their  technological  detection  limits;  Section  4  reviews  the  14  major  breath 
biomarkers that have been detected in actual human breath by the laser techniques to date; the current 
status  of  breath  sensing  instrumentation  using  the  laser  spectroscopic  techniques  is  updated  in  
Section 5; and challenges in the field of the laser spectroscopy based breath analysis are discussed in 
Section 6. 
 
2. 35 Identified Breath Biomarkers and Their Related Physiological Symptoms 
 
To date, more than 1,000 compounds have been identified to be present in exhaled human breath. 
Their concentrations range from ppb to ppt levels. Approximately, 35 of the identified compounds in 
the exhaled breath have been established as biomarkers for particular diseases and metabolic disorders. 
These biomarkers and their related diseases and metabolic disorders are listed in Table 1. Formation of 
these compounds is attributed to the biochemical reactions happening inside the body as a part of 
metabolic processes. For instance, acetone, which is produced normally in the body, primarily results 
from  the  spontaneous  decarboxylation  of  the  acetoacetate  and  to  a  lesser  extent  from  enzymatic 
conversion of acetoacetate to acetone. Detailed formation mechanisms of some of the biomarkers and 
how each of them is related to a specific disease are not  well understood. The relation between a 
biomarker and a specific disease is often multi-fold. In some cases, a breath species is a biomarker that 
is  indicative  of  about  more  than  one  disease  or  metabolic-disorder;  in  other  cases,  one  particular 
disease or metabolic disorder can be characterized by more than one chemical species. For example, 
breath nitric oxide (NO) is a biomarker for asthma, bronchieactasis, and rhinitis [51-54]; Ethane is a Sensors 2009, 9                         
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biomarker for vitamin E deficiency in children and an indicator of lipid peroxidation [55-57], and it 
serves as a bio-marker for asthma as well [58]. At the same time, hydrogen peroxide (H2O2) and 
ammonia (NH3) are also biomarkers for asthma [59,60]. Similarly, lipid peroxidation can be diagnosed 
through  analysis  of  breath  ethylene  and  pentane  [61,62].  However,  pentane  together  with  carbon 
disulfide is a biomarker of schizophrenia [63]. These features require breath analysis to be not only 
highly-sensitive but also highly-selective in order to obtain accurate information. 
Table 1. 35 established biomarkers and their physiological symptoms.
a 
Biomarkers  Metabolic Disorders / Diseases 
Acetone (OC(CH3)2)  Lung cancer, diabetes, dietary fat losses, congestive heart failure, 
brain seizure 
Acetaldehyde (CH3CHO)  Alcoholism, liver related diseases, lung cancer 
Ammonia (NH3)  Renal diseases, asthma 
Butane (C4H10)  Tumor marker in lung cancer 
Carbon monoxide (CO)  Oxidative stress, respiratory infection, anaemias 
Carbon disulphide (CS2)  Schizophrenia, coronary, and artery diseases 
Carbon dioxide (CO2) (
13C-Isotopes)  Oxidative stress 
Carbonyl sulfide (OCS)  Liver related diseases 
Ethane (C2H6)  Vitamin E deficiency in children, lipid peroxidation, oxidative stress 
Ethanol (C2H5OH)  Production of gut bacteria 
Ethylene (C2H4)  Lipid peroxidation, ultra violet radiation damage of skin 
Hydrogen (H2)  Indigestion in infants, intestinal upset, colonic fermentation 
H/D isotope  Body water 
Hydrogen peroxide (H2O2)  Asthma 
Hydrogen cyanide (HCN)  Pseudomonas aeruginosa in children affected with cystic fibrosis 
8-Isoprostane  Oxidative stress 
Isoprene  Blood cholesterol 
Methane (CH4)  Intestinal problems, colonic fermentation 
Methanethiol (CH3SH)  Halitosis 
Methanol (CH3OH)  Nervous system disorder 
Methylated amines  Protein metabolism in body 
Methyl nitrate (CH3NO3)  Hyperglycemia in Type 1 diabetes 
Nitrogen monoxide (NO)  Asthma, bronchiectasis, hypertension, rhinitis, lung diseases 
Nitrotyrosine (C9H10N2O5)  Asthma 
Oxygen (O2)  Respiration 
Pentane (C5H12)  Peroxidation  of  lipids, liver diseases,  schizophrenia,  breast  cancer, 
rheumatoid arthritis 
Pyridine (C5H5N)   Periodontal disease 
Sulfur compounds  Hepatic diseases and malordor, lung cancer 
Hydrocarbons (Toulene (C6H5CH3), 
Benzene (C6H6), Heptane (C7H16), 
Decane (C10H22), Styrene (C8H8), Octane 
(C8H18), Pentamethylheptane (C12H26)) 
Lipid peroxidation, lung cancer, oxidative stress, airway 
inflammation 
a Note that except for NO, the only one that has been approved by the U.S. Food and Drug Administration as 
a biomarker of chronic airway inflammation in asthma, other breath compounds listed in Table 1 should be 
more accurately termed as ― potential biomarkers‖ while the term ― biomarker(s)‖ is used throughout the paper. Sensors 2009, 9                         
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Different techniques that are being used in the detection and measurement of breath compounds can 
be  categorized  into  three  major  groups:  GC-MS  or  other  MS-based  methods,  laser  absorption 
spectroscopic techniques, and electrical sensors. Detection  limits of  breath compounds using these 
techniques are in the range of ppm – ppt. Although all of these techniques have their own advantages 
and disadvantages, which have been intensively discussed in the literature [25-30], almost all of the 
breath compounds are initially identified and quantified by using the MS-based methods. Driven by 
the  ultimate  goals  of  noninvasive  breath  analysis  for  clinical  application  and  home-owned  POC 
medical instrumentation, laser spectroscopic breath analysis  has begun to draw increasing attention 
during the last several years since advanced spectroscopic techniques, together with new laser sources, 
have made it possible to develop a POC instrument for online monitoring and analysis of human breath 
with  high  accuracy,  sufficiently  low  detection  limits,  and  affordable  cost.  The  major  laser 
spectroscopic techniques, which are characterized by their high sensitivities and are currently being 
used or underdevelopment for breath analysis, include TDLAS, CRDS, ICOS, CEAS, CALOS, PAS, 
QEPAS, and OFC-CEAS. The basic principles of these techniques are briefly described below.  
 
3. Laser Spectroscopic Techniques for Breath Analysis 
 
Tunable  diode  laser  absorption  spectroscopy  (TDLAS)  is  an  optical  technique  combining  the 
conventional absorption spectral method with advanced tunable diode lasers [31,32]. In TDLAS, a 
sample gas is contained in a gas cell and a detector records the transmitted laser intensity as the laser 
wavelength is repetitively scanned through the central frequency  of an absorption line of the gas. The 
relation between the incident laser intensity I0 and the transmitted intensity I is expressed by the Beer-
Lambert law: 
L e I I
) (
0 ) ( ) (
   
              (1)  
where L is the optical path-length and () is the absorption coefficient at frequency . () is related 
to the absorption cross-section () by:  
n ) ( ) (                    (2)  
where n is the concentration of the sample gas (molecule cm
−3). In many cases, the absorption line has 
a pressure- and temperature-dependent lineshape that is centered on the central frequency. Absorption 
is  more accurately quantified  by  an  integrated absorption over the entire absorption  lineshape and 
expressed by a total single-pass absorbance A, which is defined as: 
A = absorbance SnL d nL d L     
 
0 0
) ( ) (              (3) 
where S is the line strength defined as: 



0
) (    d S              (4)  
For a given transition line, the line strength is a function of gas temperature. Line intensities of 
spectral transitions of many important application-driven molecules are documented in the literature 
and have an accuracy of 1%–5% or better [64]. Equation (3) indicates that for a given experimental Sensors 2009, 9                         
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system  (a  fixed  L),  a  transition  line  with  a  larger  line  strength  S  allows  a  lower  detectable  gas 
concentration n. Rearranging Equation (1) gives that the detection limit (DL) in terms of the minimum 
absorbance Amin is determined by the minimum detectable fractional change of the laser intensity, ΔI/I0, 
where ΔI = I0 – I. The stability of the light source and electronic noise of the detector typically offer an 
Amin on the orders of 10
–2–10
–4. Compared with this direct measurement of the intensity difference ΔI, 
TDLAS measurements are frequently carried out by using the harmonic detection technique, called 
wavelength  modulation/frequency  modulation  spectroscopy  (TDLAS-WM/FM)  [65,66],  in  which  a 
better signal-to-noise ratio resulting from the wavelength/frequency modulation scheme yields a lower 
detection limit (DL) for TDLAS-WM/FM of 10
–4–10
–6. If a multipass gas cell, e.g., a Herriott cell, is 
implemented  in  the  TDLAS-WM/FM  technique,  DLs  can  be  further  lower.  A  Herriott  cell  is  a  
multi-pass optical cavity which consists of two concave spherical mirrors separated by a fixed distance. 
The inlet beam is injected into the cell at a small angle through a hole in one of the mirrors. Under the 
condition of an appropriate alignment, the beam exits at an angle different from the injection angle 
through the same hole after multiple passes through the cell. In a typical case, the beam bounces back 
and forth between the two mirrors tracing an elliptical spot pattern on each mirror. Using a Herriott 
cell,  the  effective  path-length  can  be  typically  increased  up to tens to  100-fold.  Thus  DLs  of  the 
TDLAS-WM/FM technique combined with a Herriott cell can be as low as 10
–8. 
Figure 1. Illustration of the CRDS concept. The effective absorption path-length is readily 
increased more than 10,000-fold in CRDS. With and without absorption the decay time 
constants (ringdown times) are different; a ringdown decay example is shown in the right. 
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Cavity ringdown spectroscopy (CRDS) is a laser absorption technique [33-36], as pictorially  in  
Figure 1. It obtains high sensitivities because of the multipass nature of the optical absorption path. It 
can be coupled to high resolution laser sources without adverse impacts from the intensity variation of 
the laser source.
 In CRDS, a laser beam is injected through one end-mirror of an optical cavity, where 
the injected light remains trapped between the mirror surfaces. The intensity of the light in the cavity 
decays exponentially with time at a rate determined by the round trip losses experienced by the laser 
pulse. These losses are typically due to the finite reflectivity of the cavity mirrors, optical absorption, 
and/or  scattering.  The  decay  behavior  can  be  monitored  by  a  photodetector  located  behind  the  
second mirror.  Sensors 2009, 9                         
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In the simplest case, where there are no absorbing species present, the decay time (ringdown time), 
τ0, is determined  by the speed of  light,  c, the mirror reflectivity,  R, and the distance between  the 
mirrors, d: 
) 1 (
0 R c
d

                 (5) 
If a sample gas fills the optical cavity, there are additional losses due to absorption by the sample 
and the decay time is given by equation (6a). If the gas fills only a portion of the cavity, l, then the 
mirror separation, d, must be distinguished from l (the length of the absorption path), as in equation 
(6b): 
) ) ( 1 ( nd R c
d
 

 
           (6a) 
) ) ( 1 ( nl R c
d
 

 
            (6b) 
Experimentally, one measures the ringdown lifetimes with absorption () and without absorption 
(0). Thus, the absorbance can be rewritten as: 
A = absorbance =   )
1 1
(
0  
   
c
d
nl         (7) 
Equation (7) can be rearranged as:  
      / ) 1 (    R nl   (       0 )       (8) 
Given mirror reflectivities in the near infrared (NIR) of ~99.9985 % and Δτ/τ measurable to ~10
–3, 
the detection limit of the single-pass absorbance is on the order of 10
–8.  
Integrated cavity output spectroscopy (ICOS), cavity enhanced absorption spectroscopy (CEAS), 
and  cavity  leak-out  absorption  spectroscopy  (CALOS)  are  the  same  technique  but  just  named 
differently in the literature [37-40,41-46]. They are variants of the original CRDS technique and share 
the same multipass scheme to enhance sensitivity. The difference between these variants and CRDS is 
that, e.g., ICOS measures the integrated output of the light intensities with and without absorption of 
the species in the gas cell and the absorbance is determined by: 
absorbance = 
0
) 1 (
I
I
R

           (9) 
Upon comparison of Equation (8) with Equation (9), one finds that ICOS (or CEAS or CALOS) has 
similar detection sensitivity to CRDS. Although ICOS seems to be more robust in terms of the optical 
alignment requirements than CRDS, the determination of the mirror reflectivity in ICOS still requires 
CRDS  measurements.  With  a  broadband  laser  source,  ICOS  (or  CEAS  or  CALOS)  can  measure 
several species concurrently or obtain a spectrum over a broad spectral window. Figure 2 shows the 
ICOS spectra of O2 obtained over a wide wavelength range. Sensors 2009, 9                         
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Figure 2. The combined time-domain and broadband ICOS spectra of the weak oxygen  
b-x (1,0) band is clearly seen. The broadband-ICOS spectrum can be recovered by doing a 
linear  integration  along  a  line  at  any  constant  height  (the  time  axis  in  the  Spectral 
Photography  image)  (reproduced  with  permission  from  the  Optical  Society  of  
America [37]).  
 
Figure 3. Schematic of photoacoustic spectroscopy. 
 
 
Photoacoustic spectroscopy (PAS) differentiates itself from CRDS and the CRDS variants by using 
a sensitive microphone to sense acoustic waves launched by the absorption of pulsed or modulated 
radiation via transient localized heating and expansion in the absorbing medium. In PAS, as illustrated 
in Figure 3, the absorbing medium, e.g., a gas sample, in a specially designed PAS cell absorbs laser 
radiation at a selected frequency and the photon energy absorbed by the gas is translated into kinetic 
energy of the gas  molecules or gas pressure variations through non-radiative relaxation processes. 
Unlike  TDLAS  and  CRDS,  PAS  does  not  directly  measure  light  absorption,  but  the  detection 
selectivity of PAS for a gas species is still based on the resonance of the laser frequency with the 
selected  transition  frequency  of  the  gas  molecules.  Based  on  the  same  photoacoustic  effect,  the 
acoustic waves generated from the absorption of the gas sample translates the acoustic energy to a 
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narrow band acoustic transducer, e.g., a quartz tuning fork, and a resonant signal is detected when the 
acoustic wave is resonant with the vibration frequency of the fork; this new approach is named the 
quartz-enhanced PAS (QEPAS) [48]. In the original form of PAS for the detection of gas molecules, 
the detection  limit (in terms of absorbance)  is determined by the  minimum detectable PAS signal 
(sound pressure), Pmin, laser power, WL, the setup constant of the PAS cell, C, and laser absorption 
path-length, L, which can be expressed as [67]: 
L CW
L P
L v absorbance A
min
min min ) (             (10) 
For example, the background noise of a typical PAS detector is 100 nV–1 mV and the sensitivity of 
a typical PAS microphone is ~100 mV/Pa. The minimum detectable sound pressure is in the range  
of 10
–5–10
–7 Pa. Given a setup constant of 2,000 Pa cm/W and absorption path-length of 10 cm, the 
detection limit, Amin, of the PAS system will be on the order of 10
–6–10
–8 at a laser power of 1 W. 
Using different novel approaches to address issues associated with background noises, PAS cell design, 
sensitivity  of  the  detector,  and  signal  processing  methods,  the  detection  limit  can  be  effectively 
reduced to 10
–7–10
–9. Depending on different gas molecules, trace gases can be detected by the PAS 
technique at ppm – ppb levels. 
Combining  the  new  optical  frequency  comb  technology  with  the  CEAS  technique,  Ye  et  al. 
introduced OFC-CEAS [49], which combines high-sensitivity of the cavity enhancement technique 
with a broadband laser source, and demonstrated simultaneous detection of multiple breath species, as 
illustrated in Figure 4 [50]. The OFC-CEAS technique takes advantage of high peak intensities of the 
pulsed output to reach a wide spectral range from the UV to the far infrared via a nonlinear conversion 
process and creates a parallel detection scheme that records a large spectral bandwidth in a single laser 
shot. An  initial OFC-CEAS system using a  mode-locked fiber  laser has demonstrated a minimum 
detectable absorption coefficient of 8  10
–10 cm
–1 (corresponding to an Amin of 4  10
–8 at a gas cell 
length of 50 cm) in a 200 nm spectral window in the NIR. Like the other forms of high-sensitivity laser 
spectroscopic techniques, the detection sensitivity of the OFC-CEAS can be further improved by 2–3 
orders of magnitude when the operation of the frequency comb technology extends to the mid-infrared 
(MIR) spectral region.  
Figure  4. Schematic of the cavity-enhanced direct-frequency-comb spectrometer, along 
with the gas handling system for breath analysis (reproduced with permission from the 
Optical Society of America [50]). 
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4. Breath Biomarkers Detected by the Laser Spectroscopic Techniques 
 
Of the 35 major breath biomarkers listed in Table 1, 14 biomarkers have been detected in actual 
human breath by the aforementioned laser spectroscopic techniques; some of the breath biomarkers 
have not been measured in actual breath gases to date, but have been measured in specially calibrated 
gas samples, which contain the biomarker of interest. The rest of the biomarkers have not been studied 
by the laser techniques so far. The spectral fingerprints of the 14 biomarkers range from the UV to the 
MIR. Selection of a spectral fingerprint for the detection of each breath species is based on an overall 
consideration of detection sensitivity, potential spectral interferences, availability of laser sources, and 
costs  of  potential  breath  sensors.  Spectral  fingerprints,  laser  techniques,  detection  limits,  and 
corresponding literature references of each of the 14 biomarkers which have been detected with actual 
human breath by the laser techniques to date are listed in Table 2. It should be clearly noted that 
several  biomarkers,  such  as  butane  (C4H10)  [68],  hydrogen  peroxide  (H2O2)  [69],  HCN  [70,71],  
H2S [72-74], etc. listed in Table 1, which have been analyzed in non-breath gas samples by using  
laser-based techniques and can potentially be adopted for analysis of the biomarkers in actual breath, 
are  not  included  in  Table  2.  Details  of  the  breath  analysis  of  these  14  biomarkers  using  the  
high-sensitivity  laser  techniques  are  described  below  in  alphabetic  order  of  their  common  
chemical names. 
Table 2. Spectral fingerprints, laser spectroscopic techniques used, and detection limits 
achieved for the 14 major biomarkers, which have been analyzed with actual human breath 
by the laser spectroscopic techniques. The numbers in the parenthesis in the Column 4 
indicate the measuring times in which the corresponding detection limits were achieved. 
Breath bio- markers 
(chemical formula) 
Spectral 
fingerprints  
(UV-MIR) (µ m) 
Laser 
spectroscopic 
technique 
Detection limits/ 
Measured 
concentrations 
References 
Acetaldehyde 
(CH3COH) 
5.79  TDLAS  80 ppb (5 sec)  Kamat et al. [75] 
Acetone (OC(CH3)2)  0.266   CRDS  0.2 ppm  Wang et al. [76-78] 
Ammonia (NH3)  9–10.7   PAS  100 ppm (3 sec)  Narasimhan et al. [79] 
NH3  11.0   TDLAS  1 ppm (10 sec)  Lachish et al. [80] 
NH3  10.0   TDLAS  50 ppb (20 sec)  Manne et al. [81] 
NH3  10.0   TDLAS  3 ppb (10 sec) 
4 ppb (5 sec) 
Manne et al. [82] 
NH3  10.3   TDLAS  5 ppb (30 sec)  Moskalenko et al. [83] 
NH3  1.5   OFC-CEAS  4 ppm  Thorpe et al. [50]  
Carbon dioxide and C-
isotope [CO2 & 
13CO2/
12CO2] 
4.23   PAS  7 ppb  Herpen et al.  
(CO2 from insects in 
atmosphere) [84] 
CO2  1.6   CRDS  3 ppm  Crosson et al. [85] 
CO2  1.59
  TDLAS/WM  100 ppm  Weldon et al. [86] 
CO2  4.9   TDLAS  0.5 ppm (50 µs–1 ms)  Moskalenko et al. [83]  
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Table 2. Cont. 
CO2  4.8   TDLAS  ~5.1% as compared 
with a spectrum of 5% 
CO2 in air. 
Wysocki et al. [87] 
CO2  4.9   CALOS  (3.778 ± 0.004)%  Halmer et al. [46] 
CO2  5.2   ICOS  -  McCurdy et al. [88] 
13CO2/
12CO2  1.6 
  CRDS  Precision, 0.2‰  Crosson et al. [85] 
13CO2/
12CO2  1.6 
  OFC-CEAS  Precision, 4.1‰  Thorpe et al. [50] 
Carbon monoxide (CO)  1.6  OFC-CEAS  900 ppb  Thorpe et al. [50] 
CO  4.6   TDLAS  0.5 ppm  Moskalenko et al. [83] 
CO  4.88   TDLAS  -  Lee et al. [89] 
Carbonyl sulphide (OCS)  4.86   TDLAS  1.2 ppb  Wysocki et al. [87] 
OCS  4.86   TDLAS with Thermo- 
electrically QC laser 
30 ppb  Roller et al. [90] 
OCS  4.9   CALOS  438 ppt  Halmer et al. [88] 
D/H isotopic ratio 
(D2O/H2O) 
3.50-3.65  TDLAS  55.2% ± 1.8% body 
water 
Bartlome et al. [91] 
Ethane (C2H6)  3.4   OA-ICOS  0.12 ppb  Parameswaran et al. [92] 
C2H6  3.4  TDLAS  0.1 ppb  Skeldon et al. [93] 
C2H6  3.3  CALOS  270 ppt  Halmer et al. [45] 
C2H6  3.0   CALOS   100 ppt  Dahnke et al. [43] 
C2H6  2.6–4.0  CALOS  500 ppt (<800 ms)  von Basum et al. [44] 
C2H6  3.4   TDLAS   0–12 ppb   Patterson et al. [94] 
C2H6  3.3   PAS  -  Puiu et al. [95] 
C2H6  3.4   TDLAS/WM   70 ppt  Skeldon et al. [96] 
Ethylene (C2H4)  10.5   PAS   -  Puiu et al. [95] 
C2H4  9.2−10.8   PAS  -  Dumitras et al. [97] 
Formaldehyde (CH2O)  3.53   ICOS   150 ppb  Miller et al. [98] 
CH2O  3.53   TDLAS  320 ppt  Rehle et al. [99] 
CH2O  3.53  CALOS  2 ppb  Dahnke et al. [100] 
CH2O  3.53   PAS   3 ppb  Angelmahr et al. [101] 
CH2O  3.53   QEPAS   0.6 ppm (10 sec)  Horastjann et al. [102] 
CH2O  3.53  TDLAS   77 ppt (1 min)  Richter et al. [103] 
CH2O  3.53   TDLAS  1.2 ppm  Ciaffoni et al. [104] 
Methane (CH4)  3.35   TDLAS  0.5 ppm (50 µs –1 ms)  Moskalenko et al. [83] 
Methylamine (CH3NH2)  1.51−1.53  CRDS  2.3 ppm  Marinov et al. [105] 
Dimethylamine 
(CH3)2NH3) 
1.51−1.53   CRDS  10 ppm  Marinov et al. [105] 
Nitric Oxide (NO)  5.2   ICOS   1 ppb (4 sec)  Silva et al. [39] 
NO  5.2   TDLAS  2 ppb  Namjou et al. [106] 
NO  5.2   TDLAS  3 ppb (200 sec)  Menzel et al. [107] 
NO  5.2   CEAS  16 ppb  Menzel et al. [107] 
NO  5.2   CRDS   0.7 ppb  Kosterev et al. [108] 
NO  5.2   TDLAS  1.5 ppb (4 sec)  Roller et al. [109] 
NO  5.2  TDLAS  2 ppb  Namjou et al. [110] 
NO  5.2   ICOS  400 ppt (<1 sec)  McCurdy et al. [88] 
14NO and 
15NO  5.0   CALOS  7 ppt (70 sec)  Heinrich et al. [111] Sensors 2009, 9                         
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Acetaldehyde (C2H4O) Acetaldehyde has been identified as a biomarker for alcoholism and lung 
cancer  [18,112].  Normal  human  breath  acetaldehyde  ranges  from  0  to  140  ppb  [113].  Only  one 
publication has reported the investigation of acetaldehyde  in exhaled human breath  [75], in which 
measurements  of  acetaldehyde  in  exhaled  breath  following  the  ingestion  of  375  mL  of  wine  
(12.5%  alcohol)  were  conducted  by  using  the  TDLAS  technique.  Acetaldehyde  exhibits  a  strong 
absorption band in the spectral range of 5.49–5.75 m (1,680 to 1,820 cm
–1), which is attributed to the 
υ4  band,  and  the  strongest  absorption  is  at  1,764  cm
–1.  In  that  study,  however,  the  absorption  of 
acetaldehyde near 5.79 m (1,727.1 cm
–1) was measured at 26 Torr in an astigmatic Herriott cell with 
an effective path-length of 100 m. The detection limit for the acetaldehyde was reported to be 80 ppb 
and 30 ppb for an integration time of 5 and 45 s, respectively. The authors noted that if the molecular 
fingerprint at 5.67 m (1,764 cm
-1) is used, the detection limits can be improved by a factor of 2, 
which will be close to the required detection limit, 10 ppb, for analysis of acetaldehyde in human 
breath. Measurements of acetaldehyde in non-breath gas using the laser spectroscopic techniques have 
been reported and can be read elsewhere [114,115]. 
 
Acetone ((CH3)2CO) The mean acetone concentration in healthy breath reported in the literature 
varies  from  0.39  to  0.85  ppm,  and  the  overall  mean  value  is  ~0.49  ±  0.20  ppm  
with 1 = 0.20 ppm [8,20,106]. Elevated acetone concentrations  in  the exhaled  breath of diabetic 
subjects have been reported. Elevated breath acetone also exists in exhaled breath of children who are 
on a high-fat diet for the treatment of epilepsy [117]. Acetone concentrations in human breath can also 
be an indicator of congestive heart failure and cardiac index [118,119]. CRDS of acetone in the UV 
and NIR spectral regions have been reported. Wang et al. demonstrated a portable acetone detection 
device using CRDS at a single wavelength at 266 nm and evaluated the instrument performance using 
both standard acetone solution samples and actual human breath under various situations [76-78]. A 
photograph of the portable acetone detection device is shown in Figure 5.  
Figure 5. A prototype acetone breath analyzer using pulsed-CRDS at 266 nm. Left: The 
instrumental package; right: Detailed pictorial view of the optical cavity configuration. 
   
 
Recently, a pilot-scale acetone breath analyzer has been developed and tested in both a research 
laboratory  and  a  clinical  study  with  59  human  subjects,  including  34  Type  1  diabetic  (T1D)  
patients, 10 Type 2 (T2D) diabetic patients, and 15 nondiabetic people [77]. The preliminary results 
include: (1) The mean acetone concentration in expired air of T1D subjects is 2.2 ppm. (2) Within the Sensors 2009, 9                         
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T1D group, the mean acetone concentration of juvenile-onset diabetic patients is significantly higher 
than  that  from  adult-onset  diabetes.  (3)  A  linear  correlation  between  the  breath  acetone  and 
simultaneous BG level is observed and the correlation coefficient is R
2 = 0.90 when all T1D subjects 
are grouped by blood glucose (BG) levels, 40–100, 101–150, 151–200, 201–419 mg per 100 mL. (4) A 
linear correlation between the mean group A1c and the mean group acetone concentration is also found 
with a correlation coefficient of R
2 = 0.92 when the A1c of the T1D subjects are grouped by <7, 7–9.9, 
and 10–13. (5) Simultaneous measurements of BG and breath acetone of three juvenile-onset T1D 
subjects over a 24-hr time period show a correlation between the variations of the breath acetone and 
the BG levels. The observation of abnormal acetone concentrations in some T1D subjects, whose BG 
levels are well controlled (lower than 100 mg per 100 mL), indicates that mild ketosis is undiagnosed 
by measuring only BG. Analysis of breath acetone may be also achieved in the VUV spectral region 
by using synchrotron radiation. Regardless the cost issue, the spectral selectivity in the deep UV could 
be advantageous. Spectral fingerprints of acetone in the deep UV down to 115 nm have been reported 
recently by Ferreira da Silva et al. [120]. 
 
Ammonia (NH3) Ammonia concentration in normal human breath is in the range of 0.25–2.9 ppm. 
Ammonia is a biomarker of renal failure, Helicobacter pyroli and oral cavity disease [121,122]. One of 
the earliest measurements of ammonia in human breath was reported by Lachish et al. [79]. They used 
the TDLAS technique combined with a high resolution MIR lead-salt light source. In the near-real 
time measurement of ammonia, the laser was locked on the peak of the absorption line of ammonia  
at 10.74 m (930.76 cm
–1). The absorption of ammonia was observed in a sample cell with a path-
length of 50 cm. The detection limit was 1 ppm with an integration time of 10 s. Manne et al. [81] 
reported a prototype breath gas analyzer based on the CRDS technique for quantification of ammonia 
in  human breath.  A thermo-electrically cooled distributed feedback (DFB) quantum cascade diode 
laser (QCDL) was used as the MIR laser source operating at 10.3 µm (970 cm
-1). The system showed a 
detection limit of 50 ppb for ammonia with a response time of 20 s. Recently, the same group has 
developed a sensor for measurements of breath ammonia with a pulsed quantum cascade laser using 
intra- and inter-pulse spectroscopic techniques. The system utilized an astigmatic Herriott gas cell with 
a 150 m effective path-length and a pulsed DFB-QCDL operating at 10.6 µm . The detection limits for 
breath ammonia of the system were 3 ppb when the system was operated in the intra-pulse method 
with an integration time of less than 10 s and 4 ppb in the inter-pulse method with an integration time 
of  ~5  s  [82].  Simultaneous  measurements  of  multiple  breath  species,  including  ammonia,  were 
demonstrated by the Ye group using the OFC-CEAS technique [50]. In that study, an NIR spectral 
window centered around 1.51 µm (6,623 cm
–1) was used, where absorptions of ammonia and water 
were relatively overlapped. Using calibrated samples with 4.4 ppm ammonia in nitrogen as a reference, 
they obtained a detection  limit of 18 ppb [50].  Moskalenko et al. reported an automated TDLAS 
system  operating  in  the  MIR  and  measured  multiple  compounds  in  smokers’  and  non-smokers’ 
exhaled  breath,  including  ammonia,  carbon  monoxide,  methane,  and  carbon  dioxide  [83].  They 
reported  ammonia  concentrations  in  the  smokers  and  non-smokers’  breath  had  no  significant 
difference and they were all in the range of 130–200 ppb. The detection limit for ammonia measured  
at 10.3 m was 5 ppb for a response time of 30 sec.  
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Carbon dioxide (CO2) and 
13C-isotope Carbon dioxide and carbon isotopes have been established 
as a biomarker of Helicobacter pyroli infections, liver malfunction, and excessive growth of bacteria in 
body etc. [123-127]. CO2 has a strong absorption around 4.3 µm (2,326 cm
–1) which allows highly 
sensitive detection of CO2 and its 
13C isotope using direct laser absorption spectroscopy with MIR 
laser sources, such as lead-salt lasers as shown by Becker et al. [128] and DFG light sources as shown 
by Erdelyi et al. [129]. Crosson et al. [85] conducted measurements of CO2 in breath samples using  
cw-CRDS with an external cavity diode laser (ECDL) at 1.597 µm (6,262 cm
–1) in a laboratory system 
at 100 Torr, a detection limit of 3 ppm for CO2 was demonstrated.  
Analysis  of  carbon  isotopes  can  be  used  for  drug  administration,  and  current  breath  analysis  
of 
13CO2/
12CO2 isotopic ratio is predominantly by a GC-MS method. While two breath carbon isotope 
studies  using  high-sensitivity  laser  spectroscopic  techniques  have  been  reported,  several  laser 
spectroscopic  measurements  of 
13C  isotope  have  been  done  with  non-breath  gases.  Crosson  et  al. 
demonstrated the determination of 
13C isotopic abundance in 
12CO2 mixed with nitrogen (5% CO2 in 
N2) using a cw-CRDS system at reduced pressures. The measurement accuracy of the 
13C isotopic ratio 
was as high as 0.22‰ [85]. Note that isotopic abundance ratio, e.g., 
13C isotopic abundance 
13C is 
typically expressed relative to the PDB standard by the common notation:  
tan 13
tan
1,000
sample s dard
s dard
RR
C
R


  
where R = 
13C/
12C, the unit of 
13C is parts per mil (‰). The international PDB standard of Rstandard 
is 0.0112372. The similar notation is used to define other isotopic abundance ratios, such as δ
18O, δ
18H, 
etc. Thorpe et al. reported measurements of breath carbon (
13C) and oxygen (
18O) isotopic ratios using 
the OFC-CEAS technique and they found the carbon (
13C) and oxygen (
18O) isotopic ratios in the 
breath samples were δ
18O = –9.1 ± 4.2‰ and δ
13C = –28.8 ± 4.1‰, respectively [50]. Erdelyi and  
co-workers measured 
13CO2/
12CO2 isotopic ratio in volcanic gas emissions using direction absorption 
spectroscopy with a dual gas cell scheme, and they demonstrated a measurement accuracy of 0.8‰  
at 4.35 μm in a field-deployable gas sensor [129]. Castrillo and co-workers reported isotopic analysis 
of 
13CO2/
12CO2  using  direct  laser  absorption  spectroscopy  with  a  DFB  diode  laser  operating  
at 2.008 μm and whose optical components were built on a 60 cm × 60 cm breadboard. Four pure CO2 
samples with known δ
13C values were measured at a low pressure of 13.5 Torr. The measurement 
accuracy of δ
13C was ~0.5‰ [130,131]. More recently, Wahl et al. have combined NIR cw-CRDS 
with a sample pre-concentration method that is usually employed in sample preparations for GC-MS 
and demonstrated measurement of δ
13C in atmosphere with a measurement accuracy of 0.2‰ [132]. 
Apart from these, Horner et al. measured CO2 using the TDLAS technique at 1.6 µm and reported a 
precision of 1‰ [133]. Nelson et al. have reported the measurements of 
13C in CO2 using a pulsed 
quantum cascade laser operating at 4.3 µm (2,326 cm
–1); they achieved 0.2‰ precision [134]. Recently, 
Dirk et al. reported measurements of 
13C in CO2 at 4.32 µm (2,315 cm
–1) by using a DFG laser system; 
they obtained a precision of 0.05‰ [135].  
 
Carbon  monoxide  (CO)  Carbon  monoxide  is  a  biomarker  of  hyperbilirubina, oxidative  stress, 
respiratory  infections,  and  asthma  [136-140].  CO  is  also  used  to  monitor  bilirubin  production  in 
smoking cessation and access the lung diffusion capacity. Moeskops et al. conducted measurements of Sensors 2009, 9                         
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CO in human breath at 4.6 m (2,176 cm,
-1) using the TDLAS technique with a thermo-electrically 
cooled DFB-QCDL [141]. A detection limit of breath CO of 175 ppb for a 0.2 s integration time was 
reported. Breath CO was also measured in smokers’ breath samples in the Ye group by using the  
OFC-CEAS technique, and they found that the average CO in exhaled smokers’ breath was 6.5 ppm  
(1,538 cm
–1), which was five times higher than the 1.3 ppm measured in non-smokers’ breath [49]. A 
detection limit of 900 ppb for CO at 1.564 μm (6,394 cm
–1) was reported. In the early work reported 
by  Moskalenko  et  al.  [83],  CO  and  CO2  were  simultaneously  measured  in  the  exhaled  breath  of 
smokers and non-smokers by a TDLAS system operating at 5.0 μm (2,000 cm
–1). CO concentrations in 
the exhaled breath of the smokers and non-smokers were in the ranges of 2–20 ppm and 0.4–0.8 ppm, 
respectively. A detection limit for CO of 50 ppb was reported.  
 
Carbonyl sulfide (OCS) Carbonyl sulfide (OCS) has been identified as a biomarker of liver-related 
diseases [142]. Elevated concentrations of OCS have been observed in patients who have undergone 
lung transplantation and have had acute allograft rejection [143]. The production of exhaled OCS is 
attributed  to  oxidative  metabolic  processes  of  carbon  disulfide  and  the  incomplete  metabolism  of 
methionine.  A  few  measurements  of  breath  OCS  using  laser  spectroscopic  techniques  have  been 
reported to date. Halmer et al. [46] reported the determination of concentrations of OCS present in 
both human breath and the atmosphere. They employed the CALOS technique in the MIR region with 
a cw-CO2 laser operating at 4.9 µm  (2,041 cm
–1). The detection limits achieved were 7 ppt and 9 ppt in 
the ambient air and breath gas, respectively. Wysocki and co-workers constructed a compact OCS 
sensor using a Herriott cell which had an effective path-length of 36 m [87]. Trace OCS gas in exhaled 
human breath was measured in the spectral range of 4.85–4.87 µm (2,054.5–2,060.5 cm
–1). The gas 
cell pressure was maintained at 60 Torr, so that the transition lines of OCS and CO2 in that spectral 
region were resolved. A detection limit of 1.2 ppb was achieved at 4.86 µm (2,058 cm
–1) for a 0.4 s 
acquisition  time.  Roller  et  al.  demonstrated  quantification  of  trace  OCS  using  a  TDLAS-based 
compact  absorption  spectrometer  with  a  thermo-electrically  cooled  MIR  tunable  QCDL  
at 4.86 µm [90], the potential of being used as a breath analyzer in measuring OCS in exhaled breath 
was  demonstrated.  A  30  ppb  detection  limit  for  OCS  was  reported.  They  also  reported  a  
high-selectivity  of  the  system  capable  of  resolving  two  stable  isotopes  of  OCS: 
16O
12C
  32S  and  
16O
12C
 34S. Apart from the OCS measurements in breath gas, Fried et al. conducted experiments to 
measure OCS in ambient air [144]. They used the TDLAS technique combined with a cryogenically 
cooled cw lead-salt laser. A detection limit of 7 ppt was reported. Fischer et al. measured trace OCS 
using  the  PAS  technique  with  a  difference  frequency  generation  (DFG)  laser  system  at  3.14  µm  
(3,185 cm
–1) [145]. The detection limit of OCS was reported to be 40 ppm.  
 
Ethane  (C2H6)  In  addition  to  being  biomarkers  of  asthma,  lipid  peroxidation,  and  vitamin  E 
deficiency as previously mentioned [55-58], ethane is also an indicator of diseases like sceloderma and 
cystic fibrosis [146,147]. Ethane concentration in human breath has been reported to be in the range  
of  0–12  ppb  [94].  A  series  of  experiments  have  been  conducted  to  measure  breath  ethane 
concentrations using different laser spectroscopic techniques. Measurements of ethane in the MIR was 
mostly conducted around 3.3 µm (3,030 cm
–1). Dahnke et al. reported for the  first time real-time 
monitoring of ethane in human breath with CALOS using a CO overtone laser operating in the range Sensors 2009, 9                         
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of 2.6–4.0 µm (2,500–3,846 cm
–1). The measurements were performed in a gas cell at 76 Torr and a 
detection limit of 100 ppt was reported. The measuring time was 5 s. The study  demonstrates the 
capability  of  the  CALOS  technique  for  fast  and  sensitive  analysis  of  fractional  ethane  in  exhaled 
human breath [43]. Figure 6 shows the recent measurement results of breath ethane, CO2, and O2 using 
the CALOS technique [45].  
Figure  6. Typical  measurement of  single-breath  concentrations  of  C2H6,  CO2,  and  O2. 
Each single expiration is analyzed separately. Only 160 s are displayed in the 360–520 s 
time  windown.  The  complete  measurement took  42  min.  (Reproduced  with  permission 
from Spinger Link [45]). 
 
 
Halmer et al. demonstrated a transportable MIR laser CALOS spectrometer for online monitoring 
of trace ethane in exhaled breath. A periodically poled lithium niobate (PPLN) crystal pumped by an 
Nd:YAG laser and a diode laser with tapered amplifier were used to construct a DFG laser source  
at 3.3 µm (3,030 cm
–1) [94]. The pressure inside the cavity was kept at 56 Torr. The reported detection 
limit for breath ethane was 270 ppt with a time resolution of 1 s. Parameswaran et al. reported a simple, 
compact system for online monitoring of ethane in human breath using the ICOS technique [92]. A 
DFB interband cascade laser operating under liquid nitrogen cooling (77 K) generated a laser beam  
at 3.34 µm (2,994 cm
–1). The pressure inside the cell was 130 Torr and the minimum detectable ethane 
concentration was 0.12 ppb/(Hz)
1/2. Skeldon and co-workers reported the application of the TDLAS 
technique in the measurements of exhaled ethane in patients with lung cancer [93]. Breath samples 
from 52 patients were collected, and a simple tunable diode laser spectrometer with a lead-salt laser  
at  3.4  µm  (2,941  cm
–1)  was  used  to  analyze  ethane  in  breath  samples.  The  measurements  were 
compared  with  the  ones  using  GC-MS.  A  detection  limit  of  0.1  ppb  was  reported.  Fischer  et  al. 
constructed  a  compact  DFG  diode  laser  combined  with  the  PAS  technique  for  measuring  the 
concentration of trace ethane [145]. Measurements were performed with the sample consisting of 9 
ppm methane and 10 ppm ethane diluted in synthetic air at a total pressure 760 Torr. A detection limit 
for ethane was reported to be 1.8 ppm.  
 Sensors 2009, 9                         
 
 
8246 
Ethylene (C2H4) Ethylene, also known as ethene, is a biomarker for ultra violet radiation damage 
of human skin and lipid peroxidation in the lung epithelium [61,148,149]. Analysis of ethylene in 
exhaled  breath  using  a  laser  spectroscopic  technique  has  only  been  reported  to  date  by  
Dumitras et al. [97] They implemented the PAS technique with a CO2 laser source to measure breath 
ethylene in a smoker and a non-smoker. A potassium hydroxide (KOH) trap was employed to trap 
breath CO2 to minimize the absorption interference, thus improve detection sensitivity. They achieved 
a 17 ppb detection limit for breath ethylene by using an 88 cm
3 volume KOH trap. Puiu et al. have also 
demonstrated a PAS based sensor for the online monitoring of ethylene [95].  
 
Formaldehyde (HCHO) Formaldehyde has been found to be a biomarker of lung cancer and breast 
cancer [150]. Laser spectroscopic techniques have proven to be very useful in detecting formaldehyde 
in  concentrations  as  low  as  ppb  levels.  Formaldehyde  has  a  strong  absorption  around  3.53  µm  
(2,833 cm
–1). Rehle et al. reported the detection and quantification of atmospheric formaldehyde using 
the TDLAS technique with a DFG laser source operating at 3.53 µm (2,833 cm
–1) [99]. The sensor was 
reported  to  have  excellent  time  resolution  (on  the  order  of  seconds)  and  continuously  operated 
unattended for a long period of time. The multipass gas cell used in that work had a 100 m effective 
path-length and constant pressure of 40 Torr. The detection limit for formaldehyde with this system 
was 0.32 ppb. The spectroscopic method was evaluated by a conventional wet chemical technique and 
the results were in agreement with each other. Richter and co-workers demonstrated the development 
of a TDLAS-based compact tunable DFG laser system for the quantification of airborne trace gases 
including formaldehyde [103]. The gas samples were contained in an astigmatic Herriott gas cell at a 
cell pressure of 40 Torr. The minimum detectable concentration for formaldehyde was reported to be 
as low as 77 ppt for an integration time of 1 min. The Murtz group demonstrated real-time detection of 
formaldehyde  present  in  ambient  air  using  the  CALOS  technique  [100].  The  experimental  setup 
consisted of a tunable CO overtone sideband laser operating at 3.5 µm (2,850 cm
–1). The experiment 
was conducted at 23 Torr, and a detection limit of 2 ppb was reported. Angelmahr et al. reported a 
laboratory-based system using the PAS technique with an OPO laser source for selective and sensitive 
detection of formaldehyde in nitrogen [101]. The system demonstrated the detection of formaldehyde 
in laboratory air without using pre-concentration processes. The measurements were conducted at the 
ν1 absorption line located at 3.5 µm (2,857 cm
–1). A detection limit of 3 ppb was reported for an 
integration time of 3 min. Miller et al. reported the detection and measurement of formaldehyde using 
the ICOS technique combined with a cw-DFG interband cascade laser at 3.53 µm  (2,833 cm
–1) [98]. A 
detection limit of 150 ppb for formaldehyde for a 3 s integration time was reported. Recently, Ciaffoni 
et  al.  performed  proof-of-principle  experiments  to  measure  atmospheric  formaldehyde  at  3.5  µm 
(2,857 cm
–1) using the TDLAS-WM technique [104]. They reported a detection limit of 1.2 ppm. Very 
recently, Horstjann et al. have measured formaldehyde using the QEPAS technique with a cw-DFG 
interband  cascade  laser,  and  a  detection  limit  of  0.6  ppm  for  a  10  s  integration  time  has  been  
reported [102].  
 
D/H isotope D/H isotopic ratio measurements in exhaled breath can be of significant importance. 
The ratio can provide information about glucose and cholesterol synthesis rates inside the body [151]. 
Measurements  of  dilutions  of  D2O  can  be  used  to  determine  the  total  body  water  (H2O)  [152]. Sensors 2009, 9                         
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Recently,  Bartlome  et  al.  have  demonstrated  breath  analysis  of  the  D/H  isotope  ratios  using  a  
home-built  tunable,  pulsed  DFG  laser  source  operating  in  the  wavelength  range  of  3.5–3.65  µm  
(2,740–2,857  cm
−1)  combined  with  a  high  temperature  multipass  gas  cell  [91].  The  minimum 
detectable absorption coefficient of the system was 2.6  10
−6 (3). Repetitive measurements of the 
deuterium isotopic abundance ratio, 
2H, were carried out before intake of D2O, and the measurement 
precision was 23‰ (1). The temporal behavior of 
2H after D2O intake was also monitored. They 
demonstrated the capability of continuous monitoring of the increase of 
2H in exhaled water vapor 
after oral ingestion of a clinically relevant amount of D2O.  
 
Methane (CH4) Methane has been identified as a biomarker for colonic fermentation and intestinal 
problems [153]. Methane can be measured based on its NIR and MIR spectral fingerprints. Several 
experiments  using  different  laser  spectroscopic  techniques  have  been  conducted  around  3.3  µm  
(3,030 cm‒1) and 7.8 µm (1,282 cm‒1). Moskalenko et al. reported the analysis of methane in human 
breath using the TDLAS technique [83]. In that study, the methane concentratons in a non-smoker and 
a smoker's breath gases were compared and the time variations of methane concentrations in the two 
subjects were investigated. The absorption  line  of  methane, belonging to the ν3 fundamental  band  
at 3.47 µm (2,882 cm‒1), was used for the detection of  methane. The experimental setup used an 
InSbAs diode laser source and a single-path cell of 2 m. The measurements were conducted at 76 Torr. 
A detection  limit of 0.5 ppm for methane was reported, which was sufficiently sensitive to detect 
methane in normal human breath, which has in average concentration of 3–8 ppm. The variation in 
methane concentration in the exhaled breath with time was also investigated. Scotoni et al. developed 
a system  for simultaneous detection of  multiple gases  including  methane. The system employed a 
resonant PAS technique with an ECDL with approximately 40 nm single-mode coarse tunability [154]. 
The photoacoustic cell had a length of 60 mm and a diameter of 2 mm. The experiment was conducted  
at 1.63 µm (6,115 cm
−1). A data fitting procedure was developed and employed to limit the need of a 
reference cell and improve the detection sensitivity. A detection limit of 6 ppm for CH4 was obtained 
with a 0.3 mW laser power. Measurements of trace methane in other than breath gases by several other 
groups can be seen elsewhere [145,155-160].  
 
Methylated  amines (MAs)  Variations  in  concentrations  of  methylated  amines  in  human  urine, 
sweat, and breath are associated with various diseases or altered metabolism in the body. Marinov et al. 
conducted  experiments  to  measure  concentrations  of  methylated  amines  in  a  synthetic  gas  
mixture  [105].  A  cavity  ringdown  spectrometer  was  developed  to  measure  the  trace  
mono-methylamine (MMA, CH3NH2) and dimethylamine [DMA, (CH3)2NH]. The first overtone of the 
NH stretch vibration around 1.52 µm (6,579 cm
−1) was chosen as the spectral fingerprint, where both 
MMA  and  DMA  showed  modest  absorption  at  1.52  µm.  The  minimum  detectable  absorption 
coefficient was 1.55  10
-8 cm
−1 (1), corresponding to detection limits of 350 ppb and 1.6 ppm for 
MMA  and  DMA  in  synthetic  non-absorbing  mixtures,  respectively.  These  detection  limits  are 
equivalent to 10 ppm and 60 ppm for MMA and DMA, respectively, in exhaled human breath.  
 
Nitric  oxide  (NO)  Along  with  being  a  well-established  biomarker  for  diseases  like  asthma, 
hypertension, and rhinitis [51-54], nitric oxide (NO)  is also considered as  non-invasive  biomarker  Sensors 2009, 9                         
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of  air  way  inflammation  like  lipopolysaccharide-induced  airway  inflammation,  and  lung  
inflammation [161-163]. Analysis of exhaled NO has been used to monitor asthma treatment using 
inhaled corticosteroids. NO is among the very few biomarkers which have been detected by most of 
the  available  laser  spectroscopic  techniques.  NO  has  a  strong  absorption  band  around  5  µm  
(2,000 cm
−1). Several publications show that NO can be detected by using laser absorption techniques 
with detection sensitivities up to the ppb levels. Roller et al. carried out real-time monitoring of breath 
NO  in  human  subjects  [109].  The  method  used  an  internal  calibration  through  simultaneously 
measuring concentrations of NO and CO2. This approach eliminated the need to calibrate the system 
with certified standard gases. The experiment was conducted with a TDLAS system in conjunction 
with a lead-salt laser operating near 5.2 µm (1,923 cm
−1). Breath samples were collected in disposable 
mouth pieces. A multipass Herriott cell with a volume of 16 L was used as the sample cell in the 
experiment. The detection limit obtained for NO was 1.5 ppb for a 4 s integration time. The effect of 
sample cell pressure, exhalation times, and ambient NO concentration on the measurements of the 
breath NO were also studied. The system demonstrated suitableness  for clinical application [109]. 
McCurdy  et  al.  reported  a  laboratory-scale  ICOS-based  NO/CO2  sensor,  capable  of  performing  
real-time measurements of NO and CO2 in a single breath cycle [88]. The system employed a cw-DFB 
quantum cascade laser operating at 5.22 µm (1,915 cm
−1) and a high finesse cavity with a cell length  
of 50 cm and sample volume of 60 mL. The instrument was capable of measuring CO2 and NO in 
exhaled human breath simultaneously. Prior to the analysis, the ICOS sensor was calibrated with a 
standard reference mixture of 76 ppb NO in N2. The sample flow rate into the ICOS system was kept 
fixed  at  300  mL/min.  With  human  breath  samples,  a  detection  limit  of  less  than  1  ppb  in  a  4  s 
integration  time  at  100  Torr  was  reported.  Additionally,  the  performance  of  ICOS  sensor  was 
compared  with  a  commercially  available  chemiluminescent  NO  analyzer.  The  sensor  showed  the 
capability of detecting multiple clinically important VOC's. Namjou et al. demonstrated measurements 
of NO in the MIR in a diverse sample population using an experimental setup based on the TDLAS 
technique [110]. The experiment was conducted at 5.22 µm (1,916 cm
−1) with a cryostat-housed lead-
salt tunable semiconductor laser source. The system used a  0.3 L astigmatic Herriott cell  with an 
optical path-length of 36 m. The gas pressure inside the cell was maintained at 45 Torr. Breath samples 
were collected from 799 human subjects with their ages ranging from 5 to 64. The absolute values of 
NO were quantified using NO/CO2 absorption ratios. The concentration of CO2 was measured by a 
non-dispersive  infrared  CO2  sensor,  which  was  coupled  with  the  TDLAS  system.  The  minimum 
detectable concentration for NO was reported to be 2 ppb. This technique was shown to be free from 
the regular routine calibration using standard cylinder gases. Recently, Heinrich and co-workers have 
reported online measurements of 
15NO/
14NO in nasal air using a newly constructed CALOS-based 
spectrometer [111]. The experiment was performed at 5.3 µm (1887 cm
−1). The leak out signal was 
detected  with  a  liquid  nitrogen cooled  InSb  photodetector.  The  pressure  was  set  at  53  Torr.  The 
minimum  detectable  concentration  was  7  ppt  for  an  integration  time  of  70  s.  Bakhirkin  et  al. 
demonstrated the potential of an ICOS spectrometer for the detection and measurement of NO in the 
exhaled breath [39]. The spectrometer implemented a thermo-electrically cooled pulsed QCDL as the 
laser source and a high finesse ringdown cavity that had two highly reflective mirrors (R > 99.97%) 
separated  50  cm,  generating  an  effective  optical  path-length  of  1.5  km.  The  system  showed  the 
capability of measuring both NO and CO2 simultaneously. The study achieved a detection limit for NO Sensors 2009, 9                         
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in breath samples of <1 ppbv with a 4 s integration time. Menzel et al. demonstrated a system based on 
the CEAS technique for measuring atmospheric NO, and the potential of the system for biomedical 
application  was  investigated  [107].  The  system  utilized  a  cw-QCDL  laser  operating  at  5.2  µm  
(1,923 cm
−1) under cryogenic conditions. With a cavity length of 35.5 cm, equivalent to an effective 
path-length of 670 m, they obtained a detection limit of 16 ppb with an integration time of 200 s. The 
same group used the same QCDL system, operating at the liquid nitrogen temperature and 50 Torr, 
with  an  effective  optical  path-length  of  100  m,  they  achieved  a  detection  limit  for  NO of  3  ppb. 
Moeskops et al. explored the capability of using a single mode thermo-electrically cooled cw- QCDL 
to detect and measure NO in sub ppb levels [141]. The thermo-electrically cooled cw-QCDL operating 
between  5.41–5.39  µm  (1,847  and  1,854  cm
−1)  was  combined  with  wavelength  modulation 
spectroscopy and an astigmatic multipass cell with an effective optical path of 76 m was used. They 
achieved a detection limit of 0.2 ppb for NO in N2 with a 30 s integration time at 76 Torr and 5.4 µm . 
Kosterev et al. reported measurements of NO  in N2 using the CRDS technique with a cw-QCDL 
operating at 5.2 µm (1,923 cm
−1) [108]. They obtained a detection limit of 0.7 ppb for an integration 
time of 8 s. This detection  limit reached the detection  limit of 1 ppb, suggested by the American 
Thoracic Society, yet the response time was still longer than the suggested value, 0.5 s. 
 
5. Current Status of Prototype and commercialized Breath Sensors 
 
Breathmeters for the detection of several breath biomarkers are commercially available from Ekips 
Technologies Inc. [164] and their clinical applications are expected to be approved by the U.S. Food 
and Drug Administration (FDA). Current  breathmeters, which are based on the TDLAS technique 
using a lead-salt laser source in the MIR, are able to detect NO, CO2 carbon isotope ratio, NH3, etc., 
biomarkers. Using the PAS technique, an array of breath sensors developed  by Pranalytica Inc. is 
commercially available for human breath analysis [165]. Breath biomarkers including NH3, CH4, H2S, 
etc. can be detected with detection limits of ppb – ppt levels. Using the original form of the CRDS 
technique  with  a  palm-size,  single-mode,  pulsed  266-nm  laser  source,  a  prototype  acetone  breath 
analyzer has been tested with healthy people and diabetic outpatients in a clinical study [76-78]. This 
prototype acetone breath analyzer, which has not yet been commercialized, is available for clinical 
testing  and  data  collection  associated  with  breath  acetone.  In  addition  to  the  breath  gas 
sensors/analyzers that have been tested in clinics, several laser spectroscopic gas sensors, as discussed 
in the preceding section, have been tested with online and/or offline breath analysis of the 14 breath 
biomarkers  listed  in  Table  2.  For  example,  a  cw-CRDS  spectrometer  has  been  demonstrated  for 
measurements of 
13CO2/
12CO2 in offline breath samples; standalone gas sensors based on ICOS and 
PAS using a QCDL have been demonstrated for measurements of trace acetone, formaldehyde, nitric 
oxide, etc. [166]. These sensors are ready for breath analysis in clinics.  
 
6. Challenges and Perspectives  
 
Challenges in breath analysis using laser spectroscopic techniques may include four major aspects: 
costs of future POC breath analyzers, spectral interferences, breath sample maneuver, and quantitative 
correlation of the concentration of a biomarker with the level of a blood-test-based diagnostic agent. Sensors 2009, 9                         
 
 
8250 
The  telecommunications  diode  lasers  are  inexpensive;  however,  they  restrict  spectroscopic 
measurements to be conducted in the NIR spectral region, where line strengths of molecular overtone 
transitions are several orders of magnitude weaker than that of electronic transitions in the UV and 
fundamental  bands  in  the  MIR.  On  the  other  hand,  the  current  UV  and  MIR  laser  sources  are 
expensive and bulky, which are not suitable for a POC instrument. For instance, bulky lead-salt lasers, 
DFG lasers, or OPO systems, operating in the MIR are only practically useful for laboratory breath 
analysis. QCDL technology has gained rapid advancement during the last ten years. They can operate 
in non-cryogenic conditions; and size and cost of QCDL systems have been significantly reduced. 
Nevertheless, the current cost of a breath sensor using a QCDL is still beyond consideration  for a 
home-owned medical care instrument.  
The interference issue is two-fold: spectroscopic interferences and bio-interferences. The former 
depends on the selection of detection fingerprints  for a biomarker. Regardless of instrument costs, 
using spectral fingerprints in the NIR would be inferior to the UV or MIR, due to the abundant NIR 
absorption of water vapor in breath and the interfering absorption of the first overtone of C-H and 
other fundamental vibrations. A careful selection of an NIR spectral fingerprint which does not overlap 
with an absorption of other molecules is achievable, but often sacrifices the detection sensitivity. The 
latter  is  determined  by  the  nature  of  each  individual  biomarker  and  its  associated  physiological 
symptoms. For instance, acetone is a biomarker for T1D; however, an epileptic patient on a high-fat 
ketogenic diet also has elevated breath acetone. In this case, more than one breath biomarker or a 
relative abundance pattern of several breath biomarkers may be developed as a breath fingerprint for a 
particular disease or metabolic disorder.  
The breath gas maneuver is a challenge especially for the laser-based breath analysis since the laser-
based breath analysis is performed via on-line, real-time breath gas introduction to the gas cell. Single 
exhaled air or multiple exhaled airs contain the dead-space air and alveolar air. Concentrations of 
VOCs coming from the oral cavity or being generated in the airways are in the dead-space air than in 
the alveolar air. Due to dilution in the dead-space, concentrations of endogenous blood-borne VOCs in 
mixed expiratory samples that are often used in breath analysis are lower than those in alveolar air. 
The American Thoracic Society recommends for a standarized procedure for the online measurements 
of exhaled NO in adults using a respiratory maneuver to separate nasal contamination from those of 
lower air origin [167]. How to handle the breath sampling (without separation of the dead space air and 
the  alveolar  air)  for on-line,  real-time,  clinical  breath  analysis  is  a  challenge  even  though  a  laser 
technique is ready for sensitive and selective measurements of a breath biomarker.  
Finally, the fourth challenge is not only related to breath analysis using the laser-based techniques, 
but is also relevant to breath analysis in general. Current research efforts in breath analysis are mainly 
focused on technology development and initial breath testing. A large scientific gap exists between a 
quantified  concentration  of  a  breath  biomarker  and  the  level  of  an  established  blood-test-based 
diagnostic agent. For example, we may obtain an accurate, near-real time, breath acetone concentration 
in  a  T1D  patient  using  the  CRDS-based  acetone  breath  analyzer,  but  we  still  do  not  know 
quantitatively the blood glucose level of the patient from the breath acetone concentration because of 
the lack of a quantitative correlation of breath acetone concentration with the blood glucose level. This 
knowledge gap makes the breath acetone measurements function as only a monitoring means, instead 
of a diagnostics means for diabetic patients.  Sensors 2009, 9                         
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Breath analysis for clinical use is in its infancy. Breath analysis using laser spectroscopic techniques 
is  only  a  very  recent  advancement.  To  some  extent,  the  advancement  takes  a  ride  on  modern 
telecommunications industries, which create a new generation of diode lasers capable of covering a 
wide  spectral  range  of  molecular  fingerprints.  Although  current  advanced  laser  sources,  such  as 
QCDLs,  are  still  too  expensive  for  a  home-owned  breath  sensor,  a  laser-based  breath  sensor  has 
already  proven  to  be  significantly  less  expensive than  an  MS-based  system.  Additionally,  modern 
coating technologies make high reflectivity mirrors technically and economically more available; thus, 
costs of constructing a high-finesse optical cavity for the CRDS, ICOS, and OFC-CEAS techniques are 
expected to be reduced significantly. These advancements will further accelerate the movement of the 
laser-based breath analysis from laboratory research to initial clinical testing. Some laser-based breath 
sensors are commercially available. However, it is worth being emphasized that laser-based breath 
analysis is a new interdisciplinary field, which involves with laser and optical engineering, physics and 
chemistry,  and  medicine.  Moving  breath  analysis  forward  requires  effective  communication  and  a 
broad  collaboration  among  spectroscopists,  optical  engineers,  and  clinicians.  While  the  MS-based 
techniques will continue to play an indispensable role in the identification and quantification of new 
breath biomarkers, laser-based breath analysis will play its unique role in POC, real-time, at-home, 
noninvasive disease diagnosis and metabolic status monitoring. 
 
7. Summary 
 
This article gives an overview on the new field of breath analysis using the high-sensitivity laser 
spectroscopic techniques: TDLAS, CRDS, ICOS, CEAS, CALOS, PAS, QEPAS, and OFC-CEAS. Of 
the 35 major established biomarkers, 14 breath biomarkers, their associated physiological symptoms, 
the  spectral  fingerprints  in  the  UV  –  MIR  and  laser  detection  techniques  used,  and  the  detection 
sensitivities achieved in actual human breath analysis have been updated. Challenges and perspectives 
of laser-based breath analysis are discussed.  
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